Some applications of radiochromium 51Cr in assessing the value of therapeutic regimes and the effects of crises in haemoglobinopathic states.
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy; D001639:Bicarbonates / Q000627:therapeutic use; D001774:Blood Chemical Analysis; D002648:Child; D002746:Chlorpromazine / Q000627:therapeutic use; D002749:Chlorprothixene / Q000627:therapeutic use; D002859:Chromium Isotopes; D004912:Erythrocytes / Q000503:physiopathology; D005260:Female; D006445:Hemoglobin C Disease / Q000188:drug therapy; D006453:Hemoglobinopathies / Q000188:drug therapy*; D006801:Humans; D008099:Liver / Q000032:analysis; D008297:Male; D011395:Promazine / Q000627:therapeutic use; D012964:Sodium; D013154:Spleen / Q000032:analysis; D013789:Thalassemia / Q000188:drug therapy; D013997:Time Factors; D014436:Typhoid-Paratyphoid Vaccines / Q000494:pharmacology
D001639:Bicarbonates; D002859:Chromium Isotopes; D014436:Typhoid-Paratyphoid Vaccines; D012964:Sodium; D002749:Chlorprothixene; D011395:Promazine; D002746:Chlorpromazine